Luye Pharma Group Ltd., backed by CITIC Private Equity, has agreed to acquire the advanced transdermal drug delivery systems business from Swiss-based pharmaceutical company Acino for €245 million, according to a company announcement. The business unit being acquired is focused on categories such as central nervous system, pain and hormone space, including Rivastigmine, Buprenorphine, Fentanyl […]
Visit ChinaMoneyNetwork.com for more daily finance news, including audio and video Internet podcasts covering important investment news and financial events in China. Follow us on Twitter @chinamoneypod subscribe to all episodes on iTunes.
Visit the original source and full text: China Money Network
Any news and links syndicated from other sources are copyright those respective websites and/or publications. We post brief synopsis and links per what the respective websites' RSS feeds provide.